Jeremy Bender - CHIEF EXECUTIVE OFFICER, Director at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Stock Symbol
DAWN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jeremy Bender - trading volume in the past year for Day One Biopharmaceuticals, Inc.

Holdings reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 654,728 $10.5M $16.08 May 16, 2024 Direct
Common Stock 270,226 $4.34M $16.08 May 15, 2024 Indirect
Restricted Stock Unit (RSU) 163,626 $2.63M $16.08 May 15, 2024 Direct Common Stock
Stock Option (right to buy Common Stock) 286,000 Jan 5, 2024 Direct Common Stock

Transactions reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership